Results 31 to 40 of about 42,599 (163)

Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failure. [PDF]

PLoS ONE, 2013
BACKGROUND: Metabolic syndrome has been shown to be associated with lower levels of plasma N-terminal pro-B-type natriuretic peptide (Nt-proBNP) in the general population.
Huai-Ren Chang, Jen-Che Hsieh, Bang-Gee Hsu, Ling-Yi Wang, Michael Yu-Chih Chen, Ji-Hung Wang   +5 more
doaj   +1 more source

Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) is a prognostic biomarker in heart failure (HF) with reduced ejection fraction. However, it is unclear whether there is a sex difference in NT‐proBNP response and whether the therapeutic ...
Melissa A. Daubert, Eric Yow, Huiman X. Barnhart, Ileana L. Piña, Tariq Ahmad, Eric Leifer, Lawton Cooper, Patrice Desvigne‐Nickens, Mona Fiuzat, Kirkwood Adams, Justin Ezekowitz, David J. Whellan, James L. Januzzi, Christopher M. O’Connor, G. Michael Felker   +14 more
doaj   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure
Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH.
Oliver Dörr, Stanislav Keranov, Paulina vanWickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
doaj   +1 more source

Correlates and Prognostic Value of Serial N‐Terminal Pro‐B‐Type Natriuretic Peptide Assay in Congenitally Corrected Transposition of the Great Arteries

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Cardiovascular biomarkers such as NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) are used for heart failure risk stratification in patients with acquired heart disease, but there are limited data about its role in patients with ...
Ahmed Bahnasy, Meena Bai, Sara Aboelmaaty, Mohamed Ellabbad, William R. Miranda, Heidi M. Connolly, Allan S. Jaffe, Alexander C. Egbe   +7 more
doaj   +1 more source

Prognostic utility of N-terminal pro B-type natriuretic peptide ratio in mixed aortic valve disease

Open Heart, 2023
Objective We aimed to assess the incremental prognostic value of N-terminal-pro-B-type natriuretic peptide (Nt-proBNP) for risk stratification in mixed aortic valve disease (MAVD) patients.Methods We included 556 (73±12 years, 37% women) consecutive ...
Erwan Salaun, Marie-Annick Clavel, Lionel Tastet, Jérémy Bernard, Guillaume Jean, David Bienjonetti-Boudreau, Frédéric Jacques   +6 more
doaj   +1 more source

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease

International Journal of Cardiology: Heart & Vasculature
Background: Atrial fibrillation (AF) screening should be considered in elderly patients with high risk of stroke, which include individuals with hypertension.
Gina Sado, Katrin Kemp Gudmundsdottir, Carl Bonander, Mattias Ekström, Johan Engdahl, Emma Svennberg   +5 more
doaj   +1 more source

Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome

Cardiology Research and Practice, 2019
Background. The diagnostic and prognostic role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in heart failure is well established. However, additional factors may influence its concentration.
Paweł Krzesiński, Wiesław Piechota, Katarzyna Piotrowicz, Grzegorz Gielerak, Agnieszka Woźniak-Kosek   +4 more
doaj   +1 more source

The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure

Clinical Interventions in Aging, 2015
Shihui Fu,1,2,* Leixing Xie,2,* Dongyun Li,1,2 Ping Ye,1 Leiming Luo11Department of Geriatric Cardiology, 2Department of Cardiology and Hainan Branch, Chinese People’s Liberation Army General Hospital, Beijing, People’s Republic of China ...
Fu S, Xie L, Li D, Ye P, Luo L
doaj  

Heart Failure With Preserved Ejection Fraction and Lower Natriuretic Peptide: Clinical Characteristics and Change in Natriuretic Peptide Levels

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Recent heart failure (HF) guidelines emphasize the importance of recognizing patients with mild elevations in NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide).
Kanako Teramoto, Kotaro Nochioka, Yasuhiko Sakata, Kunihiro Nishimura, Hiroaki Shimokawa, Satoshi Yasuda   +5 more
doaj   +1 more source

Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation

Revista Portuguesa de Cardiologia, 2018
Introduction: Natriuretic peptides are ubiquitously used for diagnosis, follow-up and prognostic assessment in various heart conditions. N-terminal pro-brain natriuretic peptide (NT-proBNP) correlates with aortic stenosis severity, however its ...
Nelson Carlos Vale, Rui Campante Teles, Sérgio Madeira, João Brito, Manuel Sousa Almeida, Tiago Nolasco, Joao Abecasis, Gustavo Rodrigues, João Carmo, Maria Furstenau, Regina Ribeiras, José Pedro Neves, Miguel Mendes   +12 more
doaj   +1 more source